Stockreport

GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administrationCo-administration of the RSV and shi [Read more]